|
|
||||||||
J Thorac Cardiovasc Surg 2008;136:1377-1378
© 2008 The American Association for Thoracic Surgery
Brief Communication |
a Department of Cardiac Surgery, Evangelismos General Hospital, Athens, Greece
b Department of Pathology, Evangelismos General Hospital, Athens, Greece
c Department of Thoracic and Vascular Surgery, Evangelismos General Hospital, Athens, Greece
d Department of Urology, Attikon University Hospital, Athens, Greece
Received for publication November 12, 2007; accepted for publication November 26, 2007. * Address for reprints: Konstantinos Spiliotopoulos, MD, Haritos 31, 106 75, Kolonaki, Athens, Greece. (Email: cvspiliotopoulos{at}hotmail.com).
Approximately 10% of metastatic tumors eventually reach the heart or pericardium, and almost every type of malignant tumor has been known to do so. Secondary neoplasms are 20 to 40 times more common than primary cardiac malignancies. In an effort to define better the broad spectrum of the metastatic tumors reaching the heart and their diverse clinical behavior, we present this rare case of a symptomatic, isolated urothelial carcinoma of the bladder metastatic to the heart.
A 66-year-old man was referred to our department for a large pericardial effusion and cardiac tamponade. He also had a nonproductive cough and a worsening progressive dyspnea of several days' duration. His medical history included a radical cystectomy and urinary diversion (ileal conduit after Bricker procedure) performed 5 years previously for a high-grade infiltrating urothelial carcinoma (World Health Organization classification) of the urinary bladder (T2N0M0), with negative results of follow-up since then.
The echocardiogram revealed a multilobular mass attached to the wall of the right atrium with no blood flow in it, extending beyond the tricuspid valve annulus and compromising its function. A subxiphoid pericardiocentesis drained approximately 2000 mL of bloody fluid, the cytologic examination of which showed many mesothelial cells and other cells with uncertain morphologic features. After the patient's condition was stabilized, he underwent chest computed tomography and magnetic resonance imaging, which revealed an enhancing cardiac mass involving the entire right side of the heart, from the right atrial appendage to the right ventricle and into the origin of the pulmonary artery (
Figure 2A). A full-body workup followed, including bone scan and computed tomographic scans of the head, chest, abdomen, and pelvis, all of which yielded negative results for other metastatic sites.
|
|
After this diagnosis the patient followed a chemotherapy regimen based on carboplatin and gemcitabine, with a 40% reduction of the size of the cardiac mass and a reduction of the pericardial effusion seen on 6-month follow-up chest magnetic resonance imaging (Figure 2B). A year after the original diagnosis, the patient is free of symptoms and has no sign of disease spread outside the heart. The size of the metastatic tumor has remained stable.
Bladder cancer is the fourth most common cancer among men and the tenth most common among women. Localized bladder cancer is classified as superficial disease, limited to the mucosa and lamina propria, or invasive disease, extending into the muscularis and beyond. Locoregional control with radical cystectomy offers the best opportunity for survival; administration of adjuvant chemotherapy to patients with organ-confined bladder cancer (stage T1 or T2) does not provide either a survival advantage or an improvement in local control after cystectomy. Dissemination of urothelial carcinoma of the bladder generally follows predictable patterns, first involving regional and juxtaregional lymph nodes, then spreading to the liver, lungs, and bones and, less commonly, involving the intestine, adrenal glands and kidneys.1
This case presents uncommon features. Isolated metastasis of bladder tumors to the heart is extremely rare, with only 2 other reported cases.2
Such a long survival—more than a year after diagnosis of the metastatic disease—has never been reported in any similar case to our knowledge, with survival among patients with cardiac metastases known to be uniformly poor. Finally, clinical manifestations were present, although cardiac metastases are usually clinically silent and rarely produce symptoms, the most common being pericardial effusion or cardiac tamponade.3,4
Because of the advanced stage at diagnosis, curative surgery is only possible for a minority of patients with cardiac metastatic tumors, especially when this is the only site of disease and the primary tumor is under control or when metastases result in right ventricular outflow tract obstruction.4,5
In this setting, surgical debulking may ameliorate symptoms and prolong survival, as may chemotherapy, which our patient elected. Otherwise, surgical therapy is usually limited to relief of recurrent pericardial effusions or tamponade, usually through subxiphoid pericardiotomy.
|
References
This article has been cited by other articles:
![]() |
A. M. Shields, S. Pomplun, R. Deshpande, and D. C. Whitaker Right ventricular metastasis of transitional cell carcinoma of the renal pelvis: successful single stage surgical treatment Interact CardioVasc Thorac Surg, February 1, 2011; 12(2): 297 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Shinagare, N. H. Ramaiya, J. P. Jagannathan, F. M. Fennessy, M.-E. Taplin, and A. D. Van den Abbeele Metastatic Pattern of Bladder Cancer: Correlation With the Characteristics of the Primary Tumor Am. J. Roentgenol., January 1, 2011; 196(1): 117 - 122. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |